Interesting development here.
Tarsons has acquired 100% stake in Nerbe R&D GmbH and Nerbe plus GmbH & Co (German Company in similar line of business, i.e., distribution of plastic labware) for a consideration of ~15 million Euros, roughly 136 Crores INR. (Assuming higher end of band mentioned in disclosure, ie. 10-15 Euros).
This acquisition is done via Tarson’s subsidiary, Tarsons Life Science Pte Ltd. and Nerbe will be a 100% step-down subsidiary of Tarsons after the closure of deal.
Interestingly Nerbe GmbH is a profitable company with 4.9 Million Euros EBITDA and 16 Million Euros of topline in FY 22, earlier years were better in terms of profitability. (Seems a distress acquisition)
Disclosure: Holding.
| Subscribe To Our Free Newsletter |
